General
Preferred name
RS-102221
Synonyms
RS 102221 hydrochloride ()
RS-102221 (hydrochloride) ()
RS-102,221 ()
RS 102221 (hydrochloride) ()
P&D ID
PD047540
CAS
187397-18-8
185376-97-0
Tags
available
drug candidate
Drug indication
Discovery agent
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Selective beta2 agonist
(Tocris Bioactive Compound Library)
DESCRIPTION
Selective 5-HT2C antagonist
(Tocriscreen Plus)
DESCRIPTION
Selective 5-HT2C antagonist
(Tocriscreen Total)
DESCRIPTION
RS 102221 is a selective 5-HT2C receptor antagonist (pKi = 8.7), and demonstrates nearly 100-fold selectivity for the 5-HT2C receptor as compared to the 5-HT2A and 5-HT2B receptors.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
RS-102221 is a drug developed by Hoffmann-La Roche, which was one of the first compounds discovered that acts as a potent and selective antagonist at the serotonin 5-HT2C receptor, with around 100x selectivity over the closely related 5-HT2A and 5-HT2B receptors. It has anxiolytic effects in animal studies, increases the effectiveness of SSRI antidepressants, and shows a complex interaction with cocaine, increasing some effects but decreasing others, reflecting a role for the 5-HT2C receptor in regulation of the dopamine signalling system in the brain.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
14
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugMAP
Guide to Pharmacology
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
Tocris Bioactive Compound Library
Tocriscreen Plus
Tocriscreen Total
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
22
Molecular Weight
612.19
Hydrogen Bond Acceptors
8
Hydrogen Bond Donors
3
Rotatable Bonds
11
Ring Count
4
Aromatic Ring Count
2
cLogP
3.55
TPSA
143.14
Fraction CSP3
0.44
Chiral centers
0.0
Largest ring
6.0
QED
0.2
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target Type
7-TM Receptors
Primary Target
5-HT2C Receptors
MOA
Antagonist
5-HT2C Antagonists
HTR2C antagonist
serotonin receptor antagonist
Member status
member
Target
HTR2A, HTR2B, HTR2C
5-HT Receptor
Pathway
GPCR/G protein
Neuronal Signaling
Solubility
Soluble in DMSO (≥ 20 mg/ml)
Source data
